2-(3-(4-chlorophenyl)-4-oxo-3,4-dihydroquinazolin-2-yl)-N-(4-ethoxyphenyl)hydrazinecarbothioamide

ID: ALA4279247

Chembl Id: CHEMBL4279247

PubChem CID: 145980742

Max Phase: Preclinical

Molecular Formula: C23H20ClN5O2S

Molecular Weight: 465.97

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCOc1ccc(NC(=S)NNc2nc3ccccc3c(=O)n2-c2ccc(Cl)cc2)cc1

Standard InChI:  InChI=1S/C23H20ClN5O2S/c1-2-31-18-13-9-16(10-14-18)25-23(32)28-27-22-26-20-6-4-3-5-19(20)21(30)29(22)17-11-7-15(24)8-12-17/h3-14H,2H2,1H3,(H,26,27)(H2,25,28,32)

Standard InChI Key:  UMWFRMXPQFHXCP-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4279247

    ---

Associated Targets(Human)

MIA PaCa-2 (5949 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Cckbr Cholecystokinin B receptor (729 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cckbr Cholecystokinin B receptor (792 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 465.97Molecular Weight (Monoisotopic): 465.1026AlogP: 4.75#Rotatable Bonds: 6
Polar Surface Area: 80.21Molecular Species: NEUTRALHBA: 6HBD: 3
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 13.09CX Basic pKa: 2.67CX LogP: 5.45CX LogD: 5.45
Aromatic Rings: 4Heavy Atoms: 32QED Weighted: 0.28Np Likeness Score: -1.83

References

1. Kumari S, Chowdhury J, Sikka M, Verma P, Jha P, Mishra AK, Saluja D, Chopra M..  (2017)  Identification of potent cholecystokinin-B receptor antagonists: synthesis, molecular modeling and anti-cancer activity against pancreatic cancer cells.,  (7): [PMID:30108868] [10.1039/C7MD00171A]

Source